Lv3
240 积分 2022-05-11 加入
Lack of effect of aprepitant or its prodrug fosaprepitant on QTc intervals in healthy subjects
1个月前
已完结
Safety and pharmacokinetic evaluation of repeated intravenous administration of palonosetron 0.75 mg in patients receiving highly or moderately emetogenic chemotherapy
2个月前
已完结
Advanced detection, personalized treatment and equitable care: welcome to the future of oncology
2个月前
已完结
Advanced detection, personalized treatment and equitable care: welcome to the future of oncology
2个月前
已关闭
Netupitant plus palonosetron is a cost-effective treatment for the prophylaxis of chemotherapy-induced nausea and vomiting in highly and moderately emetogenic cancer treatment
2个月前
已完结
Autophagy inhibition enhances PD-1 blockade efficacy in mismatch repair–proficient colorectal cancer
4个月前
已关闭
EGFR-RAD51 fusion in lung adenocarcinoma with systemic and intracranial response to osimertinib: A case report and review of the literature
6个月前
已完结
Survival After Fertility-Preserving Hormonal Therapy vs Hysterectomy for Early-Stage Endometrial Cancer
7个月前
已完结
Comparison of oncologic outcomes between completion hysterectomy and no completion hysterectomy in patients who achieved complete response and completed childbearing after fertility-sparing treatment for early-stage endometrial cancer: Gynecologic Oncology Research Investigators coLLaborAtion study (GORILLA-3001)
8个月前
已关闭
Binimetinib versus dacarbazine in patients with advanced NRAS-mutant melanoma (NEMO): a multicentre, open-label, randomised, phase 3 trial
8个月前
已完结
皖公网安备34019202002308
